MML Investors Services
MDGL icon

MML Investors Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

MML Investors Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$742K Sell
1,418
-250
-15% -$119K ﹤0.01% 1965
2025
Q4 		$971K Buy
1,668
+278
+20% +$142K ﹤0.01% 1815
2025
Q3 		$638K Sell
1,390
-121
-8% -$45.1K ﹤0.01% 2013
2025
Q2 		$457K Buy
1,511
+2
+0.1% +$596 ﹤0.01% 2157
2025
Q1 		$500K Buy
1,509
+25
+2% +$8.21K ﹤0.01% 1988
2024
Q4 		$458K Buy
1,484
+229
+18% +$64.4K ﹤0.01% 1966
2024
Q3 		$266K Buy
1,255
+10
+0.8% +$2.56K ﹤0.01% 2260
2024
Q2 		$349K Buy
1,245
+184
+17% +$43.8K ﹤0.01% 1995
2024
Q1 		$283K Buy
1,061
+34
+3% +$8.01K ﹤0.01% 2145
2023
Q4 		$238K Buy
+1,027
New +$180K ﹤0.01% 2201
2022
Q1 		– Sell
-5,691
Closed -$482K – 2106
2021
Q4 		$482K Buy
+5,691
New +$468K ﹤0.01% 1434

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MML Investors Services's MDGL Position: Q1 2026 in Review

MML Investors Services reduced its Madrigal Pharmaceuticals (MDGL) stake by 15% in Q1 2026, selling an estimated $119K and leaving 1,418 shares worth $742K. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

MML Investors Services first reported a position in MDGL in Q4 2021 and has held it in 11 quarters since. The position peaked at $971K in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • MML Investors Services held 1,418 shares of Madrigal Pharmaceuticals worth $742K as of Q1 2026.
  • MML Investors Services sold 250 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $119K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q1 2026, its #1965 holding.
  • MML Investors Services first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
  • MML Investors Services's Madrigal Pharmaceuticals position peaked at $971K in Q4 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.